Skip to main content

Advertisement

Log in

Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

An Erratum to this article was published on 29 May 2014

Abstract

Berberine hydrochloride (BH) is an isoquinolin alkaloid with promising anticancer efficacies. Nevertheless, further development and application of this compound had been hampered by its poor aqueous solubility, low gastrointestinal absorption, and rapid metabolism in the body. In this study, a solid lipid nanoparticle (SLN)-based system was developed for efficient incorporation and persistent release of BH. The drug-loading SLNs (BH-loaded SLNs) were stable, with a mean particle size of 81.42 ± 8.48 nm and zeta potential of −28.67 ± 0.71 mV. BH-loaded SLNs showed desirable drug entrapment efficiency and drug-loaded, and the release of BH from SLNs was significantly slower than free BH. Importantly, our in vitro study indicated that BH-loaded SLNs more significantly inhibited cell proliferation on MCF-7, HepG 2, and A549 cancer cells. Meanwhile, clone formation, cellular uptake, cell cycle arrest, and cell apoptosis studies also demonstrated that BH-loaded SLNs enhanced the antitumor efficacies of BH on MCF-7 cancer cells. Taken together, our results suggest that this SLN formulation may serve as a novel, simple, and efficient system for the delivery of BH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Li AR, Zhu Y, Li XN, Tian XJ. Antimicrobial activity of four species of Berberidaceae. Fitoterapia. 2007;78(5):379–81.

    Article  PubMed  Google Scholar 

  2. Guo ZG, Lin Z, Sun RQ, Sun SQ, Wang LQ. Analysis of contents of berberine in Coptis chinensis of Lichuan. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;26(6):618–21.

    CAS  PubMed  Google Scholar 

  3. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther. 2000;294(3):822–9.

    CAS  PubMed  Google Scholar 

  4. Iwasa K, Lee DU, Kang SI, Wiegrebe W. Antimicrobial activity of 8-alkyl- and 8-phenyl-substituted berberines and their 12-bromo derivatives. J Nat Prod. 1998;61(9):1150–3.

    Article  CAS  PubMed  Google Scholar 

  5. Kupeli E, Kosar M, Yesilada E, Husnu K, Baser C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish berberis species. Life Sci. 2002;72(6):645–57.

    Article  CAS  PubMed  Google Scholar 

  6. McCarthy N, Mitchell G, Bilous M, Wilcken N, Lindeman GJ. Triple-negative breast cancer: making the most of a misnomer. Asia Pac J Clin Oncol. 2012;8(2):145–55.

    Article  PubMed  Google Scholar 

  7. Albal MV, Jadhav S, Chandorkar AG. Clinical evaluation of berberine in mycotic infections. Indian J Ophthalmol. 1986;34(1):91–2.

    CAS  PubMed  Google Scholar 

  8. Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr. 1999;13(7):442–4.

    Article  CAS  PubMed  Google Scholar 

  9. Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 2012;12(8):1113–24.

    Article  CAS  PubMed  Google Scholar 

  10. Lin K, Liu S, Shen Y, Li Q. Berberine attenuates cigarette smoke-induced acute lung inflammation. Inflammation. 2013;2013(1):1–8.

    Google Scholar 

  11. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenese-2 transcriptional activity in human colon cancer cells. Ethnopharmacology. 1999;66(2):227–33.

    Article  CAS  PubMed  Google Scholar 

  12. Jow SJ, Cha LC. Study on the physical and chemical properties of berberine as related to the biological effects. I. Acid dissociation constant. Yao Xue Xue Bao. 1965;12(9):571–6.

    CAS  PubMed  Google Scholar 

  13. Rawat DS, Thakur BK, Semalty M, Semalty A, Badoni P, Rawat MS. Baicalein-phospholipid complex: a novel drug delivery technology for phytotherapeutics. Curr Drug Discov Technol. 2013;10(3):1–9.

    Article  Google Scholar 

  14. Oh YJ, Choi G, Choy YB, Park JW, Park JH, Lee HJ, et al. Aripiprazolemontmorillonite: a New organic–inorganic nanohybrid material for biomedical applications. Chemistry. 2013;19(15):4869–75.

    Article  CAS  PubMed  Google Scholar 

  15. Parveen R, Ahmad FJ, Iqbal Z, Samim M, Ahmad S. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev Ind Pharm. 2013;2(1):2–9.

    Article  Google Scholar 

  16. Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine. 2012;7(1):1841–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Liu DY, Luo DF, Ye JT. Study on preparation of ginsenoside-Rd solid lipid nanoparticles. Chin J Hosp Pharm. 2010;30(1):25–30.

    Google Scholar 

  18. Ju H, Hao CJ, Yin F, Song LL, Chen CL, Xiao L. Preparation and characterization of curcumin solid lipid nanoparticles. Drug Eval Res. 2010;33(6):420–3.

    Google Scholar 

  19. Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, et al. Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids. Nanomedicine (London). 2012;8(7):1–16.

    Google Scholar 

  20. Cai S, Yang Q, Bagby TR, Forrest ML. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev. 2011;63(10–11):901–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Priano L, Zara GP, El-Assawy N, Cattaldo S, Muntoni E, Milano E, et al. Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration. Eur J Pharm Biopharm. 2011;79(1):135–41.

    Article  CAS  PubMed  Google Scholar 

  22. Silva AC, Gonzalez-Mira E, Garcia ML, Egea MA, Fonseca J, Silva R, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (Sln): high pressure homogenization versus ultrasound. Colloids Surf B: Biointerfaces. 2011;86(1):158–65.

    Article  CAS  PubMed  Google Scholar 

  23. Loredana S, Roberto C, Macrco D, Raffaello S, Germana M, Elisabeta M, et al. Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood mode. Eur J Pharm Sci. 2010;39(5):428–36.

    Article  Google Scholar 

  24. Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335(1–2):167–75.

    Article  CAS  PubMed  Google Scholar 

  25. Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Int J Pharm. 2012;430(1–2):238–46.

    Article  CAS  PubMed  Google Scholar 

  26. Ahmadian S, Barar J, Saei AA, Fakhree MA, Omidi Y. Cellular toxicity of nanogenomedicine in Mcf-7 cell line: Mtt assay. J Vis Exp. 2009;1(26):1–2.

    Google Scholar 

  27. Jin X, Tang S, Chen Q, Zou J, Zhang T, Liu F, et al. Furazolidone induced oxidative DNA damage via up-regulating Ros that caused cell cycle arrest in human hepatoma G2 cells. Toxicol Lett. 2011;201(3):205–12.

    Article  CAS  PubMed  Google Scholar 

  28. Jenning V, Thunemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm. 2000;199(2):167–77.

    Article  CAS  PubMed  Google Scholar 

  29. Chai YS, Hu J, Lei F, Wang YG, Yuan ZY, Lu X, et al. Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with P53/cyclin D1 and Pi3k/Akt. Eur J Pharmacol. 2013;02(41):44–55.

    Article  Google Scholar 

  30. Wang Y, Liu Q, Liu Z, Li B, Sun Z, Zhou H, et al. Berberine, a genotoxic alkaloid, induces Atm-Chk1 mediated G2 arrest in prostate cancer cells. Mutat Res. 2012;734(1–2):20–9.

    Article  CAS  PubMed  Google Scholar 

  31. He W, Wang B, Zhuang Y, Shao D, Sun K, Chen J. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma Qbc939 cells. J Pharmacol Sci. 2012;119(4):341–8.

    Article  CAS  PubMed  Google Scholar 

  32. Yan K, Zhang C, Feng J, Hou L, Yan L, Zhou Z, et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol. 2011;661(1–3):1–7.

    Article  CAS  PubMed  Google Scholar 

  33. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma Snu-5 cell line. World J Gastroenterol. 2006;12(1):21–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Athar M, Chaudhury NK, Hussain ME, Varshney R. Hoechst 33342 induces radiosensitization in malignant glioma cells via increase in mitochondrial reactive oxygen species. Free Radic Res. 2010;44(8):936–49.

    Article  CAS  PubMed  Google Scholar 

  35. Jaruga E, Salvioli S, Dobrucki J, Chrul S, Bandorowicz-Pikula J, Sikora E, et al. Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett. 1998;433(3):287–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Macao Science and Technology Development Fund (102/2012/A3) and the Research Fund of the University of Macau (SRG025-ICMS13-CMW).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Chunming Wang or Meiwan Chen.

Additional information

Lu Wang and Hongtao Li contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, L., Li, H., Wang, S. et al. Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation. AAPS PharmSciTech 15, 834–844 (2014). https://doi.org/10.1208/s12249-014-0112-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-014-0112-0

KEY WORDS

Navigation